ATH alterity therapeutics limited

Amyloid clearance by monocytes correlates with AD progression

  1. 3,040 Posts.
    lightbulb Created with Sketch. 1121
    This is a new paper from the Florey Institute by Prof. Masters et al. It is a free paper.

    They demonstrate that blood monocytes of healthy people can clear brain amyloid much more than the monocytes of MCI and AD patients. This is a new way of explaining how amyloid is eliminated from brain.

    . 2024 Sep 12;15(1):7998.
    doi: 10.1038/s41467-024-52396-1.

    Clearance and transport of amyloid β by peripheral monocytes correlate with Alzheimer's disease progression

    Affiliations
    • PMID: 39266542
    DOI: 10.1038/s41467-024-52396-1

    Abstract

    Impaired clearance of amyloid β (Aβ) in late-onset Alzheimer's disease (AD) affects disease progression. The role of peripheral monocytes in Aβ clearance from the central nervous system (CNS) is unclear. We use a flow cytometry assay to identify Aβ-binding monocytes in blood, validated by confocal microscopy, Western blotting, and mass spectrometry. Flow cytometry immunophenotyping and correlation with AD biomarkers are studied in 150 participants from the AIBL study. We also examine monocytes in human cerebrospinal fluid (CSF) and their migration in an APP/PS1 mouse model. The assay reveals macrophage-like Aβ-binding monocytes with high phagocytic potential in both the periphery and CNS. We find lower surface Aβ levels in mild cognitive impairment (MCI) and AD-dementia patients compared to cognitively unimpaired individuals. Monocyte infiltration from blood to CSF and migration from CNS to peripheral lymph nodes and blood are observed. Here we show that Aβ-binding monocytes may play a role in CNS Aβ clearance, suggesting their potential as a biomarker for AD diagnosis and monitoring.


 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.0¢
Change
0.001(11.1%)
Mkt cap ! $91.27M
Open High Low Value Volume
1.0¢ 1.0¢ 0.9¢ $9.419K 1.001M

Buyers (Bids)

No. Vol. Price($)
37 63876237 0.9¢
 

Sellers (Offers)

Price($) Vol. No.
1.0¢ 4097409 8
View Market Depth
Last trade - 16.15pm 04/07/2025 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.